Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 t...

por Mo, Zhao-Jun, Bi, Zhao-Feng, Sheng, Wei, Chen, Qi, Huang, Teng, Li, Ming-Qiang, Cui, Xue-Lian, Wangjiang, Ya-Hui, Lin, Bi-Zhen, Zheng, Feng-Zhu, Sun, Guang, Li, Ya-Fei, Zheng, Ya, Zhuang, Si-Jie, Su, Ying-Ying, Pan, Hui-Rong, Huang, Shou-Jie, Wu, Ting, Zhang, Jun, Xia, Ning-Shao
Publicado 2022

Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-...

por Chu, Kai, Bi, Zhao-Feng, Huang, Wei-Jin, Li, Ya-Fei, Zhang, Li, Yang, Chang-Lin, Jiang, Han-Min, Zang, Xia, Chen, Qi, Liu, Dong-Lin, Pan, Hong-Xing, Huang, Yue, Zheng, Feng-Zhu, Zhang, Qiu-Fen, Sun, Guang, Su, Ying-Ying, Huang, Shou-Jie, Pan, Hui-Rong, Wu, Ting, Hu, Yue-Mei, Zhang, Jun, Zhu, Feng-Cai, Xia, Ning-Shao
Publicado 2023